Modular point-of-care devices, systems, and uses thereof

Patent metadata

Field	Value
Publication number	US-11899010-B2
Application number	US-202217664790-A
Country	US
Kind code	B2
Filing date	May 24, 2022
Priority date	Oct 2, 2007
Publication date	Feb 13, 2024
Grant date	Feb 13, 2024

Abstract

The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.

First claim

What is claimed is:

1. A system for performing an assay capable of detecting an analyte in a biological sample, the system comprising:
a cartridge comprising:
a plurality of reagent units, wherein one or more of the plurality of reagent units are configured to store cartridge reagents, and
a sample vessel configured to receive the biological sample;

an assay assembly comprising:
an addressable assay unit configured to receive the biological sample and to receive a first cartridge reagent from a first reagent unit of the plurality of reagent units of the cartridge,
a reaction site arranged on an interior surface of the addressable assay unit, wherein the reaction site comprises an immobilized binding reagent configured to bind with the analyte, and
an assembly tip in fluid communication with the addressable assay unit and comprising an opening, wherein the assembly tip is configured to place the addressable assay unit in fluid communication with the first reagent unit or the sample vessel of the cartridge; and

a reader assembly configured to receive the cartridge and the assay assembly, wherein the reader assembly comprises:
an automated fluid transfer device configured to move the assay assembly relative to the cartridge to selectively place the assembly tip of the assay assembly into the sample vessel or into the first reagent unit of the plurality of reagent units and to sequentially transfer the biological sample and the first cartridge reagent into the addressable assay unit via the assembly tip such that a reaction occurs that yields a signal indicative of a presence of the analyte, and
a detection assembly configured to detect the signal indicative of the presence of the analyte.

2. The system of claim 1 , further comprising a diluent unit containing a diluent.

3. The system of claim 2 , wherein the automated fluid transfer device is configured to place the biological sample and the diluent of the diluent unit into fluid communication so as to dilute the biological sample.

4. The system of claim 1 , wherein the automated fluid transfer device comprises a head configured to engage the assay assembly and to move the assay assembly relative to the cartridge.

5. The system of claim 4 , wherein the automated fluid transfer device comprises one or more pumps to aspirate and eject fluids from the cartridge.

6. The system of claim 1 , wherein the reader assembly further comprises a temperature controlled block configured to regulate a temperature within the reader assembly.

7. The system of claim 1 , wherein the sample vessel and the plurality of reagent units are arranged in a linear array.

8. The system of claim 7 , wherein the cartridge comprises an identifier configured to encode information corresponding to contents of the cartridge.

9. The system of claim 8 , wherein the first cartridge reagent comprises a luminogenic substrate.

10. The system of claim 9 , wherein one of the plurality of reagent units of the cartridge comprises a control solution comprising a known quantity of the analyte.

11. A system for performing an assay capable of detecting an analyte in a biological sample, the system comprising:
a cartridge comprising:
a plurality of reagent units, wherein one or more of the plurality of reagent units are configured to store cartridge reagents,
a sample vessel configured to receive the biological sample, wherein the plurality of reagent units and the sample vessel are arranged in a linear array, and
an identifier configured to encode information corresponding to the contents of the cartridge;
an assay assembly comprising:
an addressable assay unit configured to receive the biological sample and to receive a first cartridge reagent from a first reagent unit of the plurality of reagent units of the cartridge,
a reaction site arranged on an interior surface of the addressable assay unit, wherein the reaction site comprises an immobilized binding reagent configured to bind with the analyte, and
an assembly tip in fluid communication with the addressable assay unit and comprising an opening, wherein the assembly tip is configured to place the addressable assay unit in fluid communication with the first reagent unit or the sample vessel of the cartridge; and

a reader assembly configured to receive the cartridge and the assay assembly, wherein the reader assembly comprises:
an automated fluid transfer device configured to move the assay assembly relative to the cartridge to selectively place the assembly tip of the assay assembly into the sample vessel or into the first reagent unit of the plurality of reagent units and to sequentially transfer the biological sample and the first cartridge reagent into the addressable assay unit via the assembly tip such that a reaction occurs that yields a signal indicative of a presence of the analyte, and
a detection assembly configured to detect the signal indicative of the presence of the analyte.

12. The system of claim 11 , wherein the immobilized binding reagent comprises an antibody or an antigen.

13. The system of claim 11 , wherein the detection assembly comprises a light source.

14. The system of claim 13 , wherein the detection assembly comprises an optical detector.

15. The system of claim 14 , wherein the signal is a fluorescent signal.

16. The system of claim 15 , wherein the analyte is procalcitonin.

17. The system of claim 15 , wherein the analyte is D-dimer.

18. The system of claim 15 , wherein the analyte is a hormone.

19. The system of claim 15 , wherein the analyte is prostate specific antigen.

20. The system of claim 15 , wherein the analyte is indicative of a sexually transmitted disease selected from the group of gonorrhea, syphilis, chlamydia , nongonococcal urethritis, yeast infection, chancroid, trichomoniasis, genital herpes, HIV I, HIV II, hepatitis A, hepatitis B, hepatitis C, hepatitis G, and hepatitis caused by transfusion-transmitted virus (TTV).

Assignees

• Labrador Diagnostics Llc

Inventors

• Burd Tammy
• Gibbons Ian
• Holmes Elizabeth A
• Frenzel Gary
• Nugent Anthony Joseph

Classifications

• G01N33/5758

  involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites · CPC title

• G01N33/54386

  Analytical elements · CPC title

• B01L3/0275

  Interchangeable or disposable dispensing tips · CPC title

• G01N35/1065

  Multiple transfer devices · CPC title

• G01N2035/103

  using disposable tips · CPC title